With the help of the data and tweets given, can you forecast whether the closing price of $bmy will climb or drop at 2017-05-09? Please state either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-04-25,-0.5,0.7,-0.5,0.7,0.7,-0.8,-1.3,-1.2,-0.5,0.2,0.9
2017-04-26,0.5,1.6,-0.1,-0.3,-0.3,-0.2,-0.9,-0.9,-0.4,0.4,1.1
2017-04-27,-0.6,0.8,-1.9,3.5,3.5,-2.9,-3.8,-4.0,-3.8,-3.1,-2.4
2017-04-28,-0.6,0.5,-1.2,0.7,0.7,-2.6,-3.8,-4.3,-4.3,-3.7,-3.2
2017-05-01,0.1,0.9,-0.7,0.5,0.5,-2.1,-3.7,-4.4,-4.6,-4.1,-3.6
2017-05-02,0.7,1.5,-0.7,-0.6,-0.6,-0.7,-2.5,-3.5,-3.8,-3.4,-3.0
2017-05-03,0.8,0.9,-0.6,-1.6,-1.6,1.4,-0.6,-1.7,-2.1,-1.9,-1.4
2017-05-04,-0.2,0.7,-0.4,0.2,0.2,0.9,-0.5,-1.6,-2.1,-2.2,-1.7
2017-05-05,0.2,0.3,-0.3,-0.1,-0.1,0.7,-0.2,-1.3,-1.9,-2.1,-1.6
2017-05-08,0.1,0.4,-0.7,-0.4,-0.4,0.6,0.5,-0.7,-1.4,-1.6,-1.3

2017-04-25: bristol-myers squibb co $bmy now covered by analysts at robert w. baird |analyst activity ¨c robert w. baird initiates coverage on bristol-myers squibb co (nyse:bmy) with a outperform  $bmy|need help 
2017-04-26: unusual options activity - 04.26.2017 - $abx $foxa $bmy $lvs $enlc $vale $x $ea $yndx |rt AT_USER here are the top 25 autoimmune brands in 2016, based on u.s. #pharma sales. $abbv $amgn $jnj $ucb $bmy
2017-04-27: rt AT_USER $bmy - the opdivo number of $1,127m beat consensus which was right around a billion.  |rt AT_USER $bmy: opdivo ahead of expectations. ww: $1.127b vs consensus of $1.031; us $761m versus con
2017-04-28: is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #
2017-04-29: #thirtythirtyrule $bmy break above the 200 sma will drive it to 60+. macd bullish and close to the 0 trendline. |#bristolmyerssquibb china approves bristol-myers squibb's dual-drug hepatitis c treatme
2017-04-30: never forget:  $bmy beats $gild, $mrk to key approvals in china, europe | stock news &amp; stock market analysis - ibd |icymi:  $bmy beats $gild, $mrk to key approvals in china, europe | stock news &a
2017-05-01: rt AT_USER on the fly: what to watch in pfizer earnings report $pfe $rhhby $nvs $bmy |bristol-myers squibb co $bmy given average rating of ¡°hold¡± by brokerages |rt AT_USER AT_USER join me here adam 
2017-05-02: rt AT_USER immunotherapy crowds bladder cancer space  $azn $rhhby $bmy $mrk |AT_USER AT_USER did an analysis on $bmy this week, interesting, r&amp;d just a hair above marketing expenses as % of sales|
2017-05-03: bristol-myers squibb: dividend cut is inevitable  $bmy|ecor1 capital llc decreases stake in bristol-myers squibb co $bmy |soothsayer " ny propaganda machine "blue crab" in full force bashing $bmy poin
2017-05-04: bristol-myers squibb co $bmy lowered to underperform at bmo capital markets |rt AT_USER $bmy starting triplet io combo in hnscc opdivo/yervoy/lirilumab|sustainable insight capital management llc takes
2017-05-05: is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #
2017-05-06: bristol-myers squibb co $bmy receives $61.68 average pt from analysts |bristol-myers squibb co $bmy receives $61.68 average pt from analysts |bristol-myers squibb (bmy): pharmaceutical firm, with most
2017-05-07: wsfs capital management llc purchases new position in bristol-myers squibb co $bmy |wsfs capital management llc purchases new position in bristol-myers squibb co $bmy |trump-care asks americans to kne
2017-05-08: rt AT_USER trump-care asks americans to kneel before political monarchy $mo $rai $pm $via $twx $unh $aet $antm $bmy $mrk $ilmn | alerted another winner. must see track record &amp; subscribe  $jah $cl
Answer:
Rise